Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline
View Patent ↗A chemistry matrix for use in determining the concentration of an analyte in a biological fluid includes a glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline. The chemistry matrix is used with an electrochemical biosensor to determine the concentration of an analyte after a reaction occurs within the biosensor, at which time an analysis is completed to determine the concentration. A method of determining the concentration of an analyte using the chemistry matrix of glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline is another aspect that is described. The method also further features test times of five seconds or less. Methods utilizing the new chemistry matrix can readily determine an analyte such as blood glucose at concentrations of from about 20-600 mg/dL at a pH of from about 6.5 to about 8.5.
1. A method for determining the concentration of an analyte in a liquid sample with reduced interference from other constituents present with the analyte, which comprises reacting the analyte with a matrix comprising glucose dehydrogenase, nicotinamide adenine dinucleotide, a nitrosoaniline and a 5-alkylphenazine quaternary salt to provide an electro-active agent, wherein said matrix is photochemically stable, measuring an electrochemical response produced by the electro-active agent, and determining the analyte concentration in the liquid sample based on the electrochemical response measured.
2. The method of claim 1 , wherein the analyte is glucose and the sample contains from about 20 mg/dL to about 600 mg/dL of blood glucose.
3. The method of claim 1 which comprises applying the sample to an application area of a biosensor having a test strip including the matrix and displaying the concentration on a display of a monitoring device configured for use with said biosensor, wherein said 5 alkylphenazine quaternary salt has the formula:
where Z is selected from the group consisting of —(CH 2 ) m COOH, —NHAc, and —OY,
where m is an integer ranging from 0 to about 6 and Y is selected from the group consisting of
where n is an integer ranging from about 1 to about 4; Q is —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) o NR 2 R 3 , —NH(CH 2 ) o OH, —NHCH 2 CH 2 —(OCH 2 CH 2 ) o -G, —(CH 2 ) o NR 2 R 3 , (—OCH 2 CH 2 ) o NR 2 R 3 and —(OCH 2 CH 2 ) o OH; and G is —COOH, NR 2 R 3 , or
R 1 is a C 1 to C 6 alkyl group, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, o is an integer ranging from about 1 to about 6; and X is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO − , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − .
4. The method of claim 3 , wherein said determining can be carried out for said sample having a blood glucose level ranging from about 20 to about 600 mg/dL.
5. The method of claim 3 , wherein said displaying occurs within about 5 seconds or less after applying said sample.
6. The method of claim 1 wherein said 5-alkylphenazine quaternary salt has the formula:
where Z is selected from the group consisting of —(CH 2 ) m COOH, —NHAc, and —OY,
where m is an integer ranging from 0 to about 6 and Y is selected from the group consisting of
where n is an integer ranging from about 1 to about 4; Q is —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) o NR 2 R 3 , —NH(CH 2 ) o OH, —NHCH 2 CH 2 —(OCH 2 CH 2 ) o -G, —(CH 2 ) o NR 2 R 3 , (—OCH 2 CH 2 ) o NR 2 R 3 and —(OCH 2 CH 2 ) o OH; and G is —COOH, NR 2 R 3 , or
R 1 is a C 1 to C 6 alkyl group, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, o is an integer ranging from about 1 to about 6; and X is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO — , CH 3 OSO 2 — , C 2 H 5 OSO 2 — , and CH 3 SO 3 — .
7. The method of claim 6 , wherein R 1 is C 2 H 5 .
8. The method of claim 7 , wherein said nitrosoaniline has the formula:
9. The method of claim 8 , wherein Z is —OY; Y is —(CH 2 ) n COOQ; Q is OH; and n=3.
10. The method of claim 8 , wherein Z is —OY; Y is —(CH 2 ) n COOQ; Q is —NHCH 2 CH 2 —(OCH 2 CH 2 ) o -G; G is —COOH; and o is 4.
11. The method of claim 8 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —NH 2 and n is 4.
12. The method of claim 8 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —OH and n is 3.
13. The method of claim 8 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —OR 2 ; R 2 is Me; and n is 4.
14. The method of claim 8 , wherein Z is —(CH 2 ) m COOH and m is 1.
15. The method of claim 8 , wherein Z is —NHAc.
16. The method of claim 6 in which the 5-alkylphenazine quaternary salt is a 5-ethylphenazine salt.
17. The method of claim 16 in which the 5-ethylphenazine salt is 1-(3-carboxypropyloxy)-5-ethylphenazine.
18. The method of claim 1 , wherein the nitrosoaniline is a compound having the formula:
and,
R 10 denotes hydrogen, halogen, alkoxy or alkylthio,
R 11 represents an alkyl or a hydroxyalky residue and
R 12 represents a hydroxyalkyl residue,
R 11 and R 12 are the same or different and each represents a dialkylaminoalkyl residue, a
hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or
R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted nitrogen residue, or
provided if R 10 is in the ortho position to NR 10 R 11 ,R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue or,
R 10 and R 12 are the same or different and each represents a hydroxyalkyl residue or a salt thereof.
19. The method of claim 18 wherein said nitrosoaniline has the formula:
20. The method of claim 1 in which the 5-alkylphenazine quaternary salt has the formula:
where R 6 is selected from the group consisting of —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) m NR 2 , —NH(CH 2 ) m OH, —O(CH 2 ) m NH 2 , and —O(CH 2 ) m OH, R 1 is a C 1 to C 6 alkyl group, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, X − is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO − , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − , and n and m are integers ranging from about 1 to about 6.
21. The method of claim 20 , wherein R 1 is C 2 H 5 .
22. The method of claim 21 , wherein said nitrosoaniline has the formula:
and,
R 10 denotes hydrogen, halogen, alkoxy or alkylthio,
R 11 represents an alkyl or a hydroxyalkyl residue, and
R 12 represents a hydroxyalkyl residue,
R 11 and R 12 are the same or different and each represents a dialkylaminoalkyl residue, a hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or
R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted
nitrogen residue, or
provided if R 10 is in the ortho position to NR 10 R 11 , R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue or,
R 10 and R 12 are the same or different and each represents a hydroxyalkyl residue or a salt thereof.
23. The method of claim 22 , wherein said nitrosoaniline has the formula:
24. A method for determining the concentration of an analyte in a liquid sample with reduced interference from other constituents present with the analyte, which comprises reacting the analyte with a matrix comprising glucose dehydrogenase, nicotinamide adenine dinucleotide, a nitrosoaniline and a photochemically stable 1-carboxyalkyloxy-5-alklyphenazine to provide an electro-active agent, wherein said matrix is photochemically stable, measuring an electrochemical response produced by the electro-active agent, and determining the analyte concentration in the liquid sample based on the electrochemical response measured.
25. The method of claim 24 , wherein the nitrosoaniline has the formula:
wherein,
R 10 denotes hydrogen, halogen, alkoxy or alkylthio,
R 11 represents an alkyl or a hydroxyalky residue, and
R 12 represents a hydroxyalkyl residue,
R 11 and R 12 are the same or different and each represents a dialkylaminoalkyl residue, a hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or
R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted nitrogen residue, or
provided if R 10 is in the ortho position to NR 11 R 12 , R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue.
26. The method of claim 25 , wherein the 5-alkyl-1-carboxyalkyloxyphenazine is a compound having the formula:
wherein where R 6 is selected from the group consisting of —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) m NR 2 , —NH(CH 2 ) m OH, —O(CH 2 ) m NH 2 , and —O(CH 2 ) m OH, R 2 is a C 1 to C 6 alkyl group, R 1 is C 1 to C 6 alkyl, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, X − is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO 31 , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − , and n and m are integers ranging from about 1 to about 6.